U.S. Stocks Ring Up Weekly Loss; Biotech Sector Routed Print
By Mark DeCambre - MarketWatch's Markets Editor   
Saturday, 26 September 2015 20:40
U.S. stocks ended the week with a whimper, turning big opening gains in the S&P 500 and Nasdaq Composite into losses by the conclusion of Friday’s session.
A sharp selloff in biotech and health-care stocks spread to broader markets, weighing on sentiment.
All three main indexes booked weekly losses, even as the Dow Jones Industrial Average eked out a gain on Friday, largely thanks to a 8.9% jump in Nike Inc. shares, which contributed 68 points to the blue-chips benchmark.
“A selloff in biotechs took the wind out of the rally. And in this low-volume environment traders are selling first and asking questions later,” said Ryan Larson, head of equity trading, U.S. RBC Global.
The iShares Nasdaq Biotechnology ETF IBB, -4.90%  plunged 4.9%, wrapping a bruising week for the sector with a 13% weekly loss. The S&P 500 health-care sector lost 5.8% over the week and closed below the lows reached on Aug 24.
“The health-care sector closed below the Aug. 24 lows. It does not bode well for sentiment when a former leader in the market is now leading on the downside,” Larson said.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!